Prolonged course of familial hemophagocytic lymphohistiocytosis

J Pediatr Hematol Oncol. 2006 Dec;28(12):831-3. doi: 10.1097/MPH.0b013e31802d3a96.

Abstract

Familial hemophagocytic lymphohistiocytosis is usually diagnosed in the first 2 years of life and, if untreated, is rapidly fatal. We describe a 10-year-old boy with a 9-year history of prolonged fever and progressive hepatosplenomegaly who was diagnosed as having hemophagocytic lymphohistiocytosis 2, being homozygote to a previously described mutation in the PRF1 gene, and cured by the HLH-2004 protocol and allogenic bone marrow transplantation. This unique case emphasizes the heterogeneity of this disease and the diversity of its clinical presentations.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bone Marrow Transplantation*
  • Child
  • Homozygote
  • Humans
  • Lymphohistiocytosis, Hemophagocytic / genetics
  • Lymphohistiocytosis, Hemophagocytic / therapy*
  • Male
  • Mutation
  • Perforin
  • Pore Forming Cytotoxic Proteins / genetics
  • Time Factors
  • Transplantation, Homologous

Substances

  • PRF1 protein, human
  • Pore Forming Cytotoxic Proteins
  • Perforin